Skip to main content
TipRanks
Go Ultimate75% OFF

OSE Immunotherapeutics SA (OSE) Q2 2022 Earnings Report

18 Followers

FR:OSE Q2 2022 EPS Results

Actual EPS
-EUR 0.11
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.64

FR:OSE Q2 2022 Revenue Results

Actual Revenue
EUR 16.05M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+78.80%

Earnings Announcement Details

Quarter
Q2 2022
Date
09/22/2022
Time
During Market Hours
Conference Call
Thursday, September 22, 2022
FR:OSE Upcoming Earnings

OSE Immunotherapeutics SA's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

FR:OSE Earnings History

FR:OSE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)―--1.01――
Sep 28, 20262026 (Q2)―--0.68―
Apr 30, 20262025 (Q4)―-1.01-0.9-11.76% (-0.11)
Oct 15, 20252025 (Q2)―-0.682.63-125.99% (-3.31)
Mar 26, 20252024 (Q4)―-0.90-0.54-67.16% (-0.36)
Sep 26, 20242024 (Q2)―2.63-0.64510.63% (+3.27)
Mar 27, 20242023 (Q4)―-0.54-0.8536.96% (+0.32)
Sep 27, 20232023 (Q2)―-0.64-0.11-481.82% (-0.53)
Apr 27, 20232022 (Q4)―-0.85-0.29-194.83% (-0.56)
Sep 22, 20222022 (Q2)―-0.11-0.6482.81% (+0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed